SCV

SCV is the trading name of Spezial-Chemikalien-Vertriebs, a Germany-based spin-out founded in 2003 from Johannes Gutenberg University Mainz focused on nuclear chemistry, nuclear medicine, and radiotheranostics. The company combines radiopharmaceutical IP licensing, consultancy for GMP-compliant radiopharmacy infrastructure, equipment and isotope distribution, and training services for nuclear medicine personnel. SCV also supports theranostic patient referral workflows in Germany, particularly for prostate cancer and neuroendocrine tumors. Its disclosed proprietary pipeline appears limited, with external pipeline databases pointing to a preclinical PSMA-targeted radiotracer program. Overall, SCV appears to operate more as a specialized radiopharma services, technology-transfer, and theranostics-enablement company than as a traditional venture-backed drug developer.